Acorn Creek Capital’s Eli Lilly LLY Stock Holding History

Acorn Creek Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.02M	Sell	1,112 -42	-4%	-$42.6K	0.37%	22
2025 Q4	$1.24M	Buy	1,154 +295	+34%	+$282K	0.45%	20
2025 Q3	$656K	Buy	859 +10	+1%	+$7.44K	0.25%	28
2025 Q2	$662K	Sell	849 -43	-5%	-$33.4K	0.27%	26
2025 Q1	$737K	Sell	892 -29	-3%	-$24.1K	0.37%	25
2024 Q4	$711K	Sell	921 -12	-1%	-$9.94K	0.37%	29
2024 Q3	$827K	Buy	933 +6	+0.6%	+$5.39K	0.44%	24
2024 Q2	$840K	Buy	927 +12	+1%	+$9.6K	0.5%	24
2024 Q1	$712K	Buy	915 +3	+0.3%	+$2.13K	0.45%	27
2023 Q4	$532K	Buy	+912	New	+$532K	0.24%	36

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Acorn Creek Capital's LLY Position: Q1 2026 in Review

Acorn Creek Capital reduced its Eli Lilly (LLY) stake by 3.6% in Q1 2026, selling an estimated $42.6K and leaving 1,112 shares worth $1.02M. The position accounts for 0.37% of the portfolio, ranked #22.

Acorn Creek Capital first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.24M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Acorn Creek Capital held 1,112 shares of Eli Lilly worth $1.02M as of Q1 2026.
Acorn Creek Capital sold 42 Eli Lilly shares in Q1 2026, an estimated $42.6K.
Eli Lilly made up 0.37% of Acorn Creek Capital's portfolio in Q1 2026, its #22 holding.
Acorn Creek Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
Acorn Creek Capital's Eli Lilly position peaked at $1.24M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Acorn Creek Capital's 13F filing for Q1 2026, filed 12 May 2026.